Clinical Trial

Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)

Study acronym: COMPAXE-HNF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to compare the accuracy of two different blood sampling methods from a central venous catheter (CVC) for measuring anti-Xa activity in children receiving unfractionated heparin (UFH) from this CVC. The results will be compared to a "gold standard" sample taken from an arterial catheter (KTA) whithout UFH. The objective is to identify a more reliable method for monitoring UFH, thereby reducing the risk of bleeding or thrombosis in these patients.
Trial Details
NCT Number NCT07365670
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Conditions Congenital Heart Disease, Unfractionated Heparin, Anti Xa Activity
Enrollment 22 participants
Start Date 2026-04-01
Primary Completion 2029-04-05 (estimated)
Study Completion 2029-04-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-26